Prosecution Insights
Prosecution Insights
Tech Center 4100 • Art Units: 1614 1626 1628 1629 1642 1691 4100
This examiner grants 80% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18572741 | Degrader Compounds and Uses Thereof | Non-Final OA | ABBVIE INC. |
| 18523284 | HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS | Non-Final OA | Genentech, Inc. |
| 18569157 | NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR | Final Rejection | LG CHEM, LTD. |
| 18642665 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | Non-Final OA | President and Fellows of Harvard College |
| 18746681 | COMPOSITIONS AND METHODS FOR STIMULATING VENTILATORY AND/OR RESPIRATORY DRIVE | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 18635130 | METHODS FOR PREPARING BUTENOLIDES | Non-Final OA | The Hong Kong University of Science and Technology |
| 18774801 | SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION | Non-Final OA | C4 THERAPEUTICS, INC. |
| 18278078 | INHIBITORS OF EPHB3 SIGNALING | Final Rejection | The Brigham and Women`s Hospital, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy